COMUNICACION INTERCELULAR
CTS-101
Harvard University
Cambridge, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Harvard University (1)
2022
-
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
Science Translational Medicine, Vol. 14, Núm. 660